volume 24, issue s2, P53-59 2011
DOI: 10.3233/jad-2011-110017
View full text
|
|
Share
Boris Decourt, Marwan N. Sabbagh

Abstract: The diagnosis of Alzheimer’s disease (AD) relies principally on clinical criteria for probable and possible AD as defined by the NINCDS-ADRDRA. The field is desperately lacking of biological markers to assist with AD diagnosis and verification of treatment efficacy. According to the Consensus Report of the Working Group on Molecular and Biochemical Markers of Alzheimer’s Disease, in order to qualify as a biomarker the sample in question must adhere to certain basic requirements, including the ability to: refl…

expand abstract